Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has experienced a shift in its substantial holdings as KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have ceased to be major shareholders as of October 24, 2024. This change in shareholding dynamics may stir interest among investors monitoring the company’s market position and stock performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
